Adaptive Biotechnologies president and COO Julie Rubinstein sells $954k stock

Julie Rubinstein, President and COO of Adaptive Biotechnologies, sold approximately 35,643 shares of company stock between November 4 and November 6, 2026, totaling around $954,441. The shares were sold at varying prices, from $25.26 to $28.04 per share. The company's stock price recently surged by 89% year-over-year, currently trading at $27.98, although some analysts believe the stock may be overvalued.

Rubinstein executed these sales under a pre-approved trading plan. She sold shares in four separate transactions, with the majority occurring on November 6, when she sold 8,400 shares at an average price of $27.32. The transactions complied with a Rule 10b5-1 trading plan agreed upon on November 18, 2025.